原发性膜性肾病中的抗磷脂酶A2受体抗体——10个关键点 - Suppr

Suppr

超能文献

Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points.

作者信息

McQuarrie Emily P

机构信息

Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital Glasgow, Glasgow, UK.

出版信息

Nephrol Dial Transplant. 2018 Feb 1;33(2):212-213. doi: 10.1093/ndt/gfx366.

DOI:10.1093/ndt/gfx366

PMID:29401359

Abstract

摘要

相似文献

Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points.原发性膜性肾病中的抗磷脂酶A2受体抗体——10个关键点

Nephrol Dial Transplant. 2018 Feb 1;33(2):212-213. doi: 10.1093/ndt/gfx366.

Circulating antibodies to α-enolase and phospholipase A receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy.日本原发性或继发性膜性肾病患者中抗α-烯醇化酶和磷脂酶A受体的循环抗体及肾小球沉积物的组成

Clin Exp Nephrol. 2017 Feb;21(1):117-126. doi: 10.1007/s10157-016-1235-2. Epub 2016 Feb 1.

Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.根据抗M型磷脂酶A2受体抗体的存在情况，特发性膜性肾病的临床特征、病程及预后

Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7.

Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.两种不同免疫抑制方案治疗的特发性膜性肾病患者中M型磷脂酶A2受体抗体滴度动态变化的预后价值

Biomarkers. 2015 Feb;20(1):77-83. doi: 10.3109/1354750X.2014.993708. Epub 2014 Dec 18.

Detection and clinical significance of glomerular M-type phospholipase A receptor in patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球 M 型磷脂酶 A 受体的检测及临床意义。

Intern Med J. 2016 Nov;46(11):1318-1322. doi: 10.1111/imj.13233.

Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。

Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.

A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.一种新型时间分辨荧光免疫分析法，用于定量检测抗磷脂酶 A2 受体抗体。

Sci Rep. 2017 Apr 11;7:46096. doi: 10.1038/srep46096.

IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study.IgG4抗磷脂酶A2受体可能在特发性膜性肾病中同时激活凝集素和替代补体途径：一项横断面研究的启示

Immunol Res. 2016 Aug;64(4):919-30. doi: 10.1007/s12026-016-8790-1.

[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].[抗磷脂酶A2受体（抗PLA2R）抗体与特发性膜性肾病：在该疾病的诊断和预后中起何种作用？]

G Ital Nefrol. 2014 May-Jun;31(3).

Membranous nephropathy and nonsteroidal anti-inflammatory agents.膜性肾病与非甾体抗炎药。

Am J Kidney Dis. 2013 Nov;62(5):1012-7. doi: 10.1053/j.ajkd.2013.03.045. Epub 2013 Jun 14.

引用本文的文献

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer.不同免疫抑制疗法对膜性肾病且抗磷脂酶A2受体（PLA2R）抗体滴度高的患者的疗效和安全性

Front Pharmacol. 2022 Jan 17;12:786334. doi: 10.3389/fphar.2021.786334. eCollection 2021.

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.来氟米特联合泼尼松治疗 PLA2R 相关原发性膜性肾病的疗效。

Ren Fail. 2020 Nov;42(1):122-130. doi: 10.1080/0886022X.2020.1713806.

Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults.血清抗磷脂酶A2受体抗体在成人原发性膜性肾病诊断及监测中的临床价值

Int J Nephrol Renovasc Dis. 2018 Sep 20;11:241-247. doi: 10.2147/IJNRD.S176665. eCollection 2018.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验